Zdrowie i gospodarka · 12/10/2023
FDA Clears CYTOXAN Drug Products for Sale
The FDA has determined that CYTOXAN (cyclophosphamide) drug products were not withdrawn from sale due to safety or effectiveness concerns. The FDA will continue to approve abbreviated new drug applications (ANDAs) for these products as long as they meet regulatory requirements.